These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1939182)

  • 1. Effects of farnesylcysteine analogs on protein carboxyl methylation and signal transduction.
    Volker C; Miller RA; McCleary WR; Rao A; Poenie M; Backer JM; Stock JB
    J Biol Chem; 1991 Nov; 266(32):21515-22. PubMed ID: 1939182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single activity carboxyl methylates both farnesyl and geranylgeranyl cysteine residues.
    Volker C; Lane P; Kwee C; Johnson M; Stock J
    FEBS Lett; 1991 Dec; 295(1-3):189-94. PubMed ID: 1765152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein prenylcysteine analog inhibits agonist-receptor-mediated signal transduction in human platelets.
    Huzoor-Akbar ; Wang W; Kornhauser R; Volker C; Stock JB
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):868-72. PubMed ID: 8430099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenylcysteine analogs to study function of carboxylmethylation in signal transduction.
    Volker C; Pillinger MH; Philips MR; Stock JB
    Methods Enzymol; 1995; 250():216-25. PubMed ID: 7651153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesylcysteine analogues inhibit chemotactic peptide receptor-mediated G-protein activation in human HL-60 granulocyte membranes.
    Scheer A; Gierschik P
    FEBS Lett; 1993 Mar; 319(1-2):110-4. PubMed ID: 8454040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and preliminary characterization of protein-cysteine farnesyltransferase.
    Manne V; Roberts D; Tobin A; O'Rourke E; De Virgilio M; Meyers C; Ahmed N; Kurz B; Resh M; Kung HF
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7541-5. PubMed ID: 2217184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenylcysteine analogs mimicking the C-terminus of GTP-binding proteins stimulate exocytosis from permeabilized HIT-T15 cells: comparison with the effect of Rab3AL peptide.
    Regazzi R; Sasaki T; Takahashi K; Jonas JC; Volker C; Stock JB; Takai Y; Wollheim CB
    Biochim Biophys Acta; 1995 Sep; 1268(3):269-78. PubMed ID: 7548225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-dependent carboxyl methylation of neutrophil G-protein gamma subunit.
    Philips MR; Staud R; Pillinger M; Feoktistov A; Volker C; Stock JB; Weissmann G
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2283-7. PubMed ID: 7892262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-prenylated cysteine analogues inhibit receptor-mediated G protein activation in native human granulocyte and reconstituted bovine retinal rod outer segment membranes.
    Scheer A; Gierschik P
    Biochemistry; 1995 Apr; 34(15):4952-61. PubMed ID: 7711017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of alpha-subunit of protein farnesyltransferase. Evidence for a catalytic role.
    Andres DA; Goldstein JL; Ho YK; Brown MS
    J Biol Chem; 1993 Jan; 268(2):1383-90. PubMed ID: 8419339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21S.
    Yoshida Y; Kawata M; Katayama M; Horiuchi H; Kita Y; Takai Y
    Biochem Biophys Res Commun; 1991 Mar; 175(2):720-8. PubMed ID: 1902099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein prenylation: a mediator of protein-protein interactions.
    Marshall CJ
    Science; 1993 Mar; 259(5103):1865-6. PubMed ID: 8456312
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoprenylation of gamma subunits and G-protein effectors.
    Fung BK; Anant JS; Lin WC; Ong OC; Yamane HK
    Methods Enzymol; 1994; 237():509-19. PubMed ID: 7935024
    [No Abstract]   [Full Text] [Related]  

  • 15. The carboxyl-terminal CXXX sequence of Gi alpha, but not Rab5 or Rab11, supports Ras processing and transforming activity.
    Cox AD; Graham SM; Solski PA; Buss JE; Der CJ
    J Biol Chem; 1993 Jun; 268(16):11548-52. PubMed ID: 8505289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.
    Bishop WR; Bond R; Petrin J; Wang L; Patton R; Doll R; Njoroge G; Catino J; Schwartz J; Windsor W
    J Biol Chem; 1995 Dec; 270(51):30611-8. PubMed ID: 8530497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of the inhibition of transducin function by farnesylcysteine analogs.
    Parish CA; Brazil DP; Rando RR
    Biochemistry; 1997 Mar; 36(9):2686-93. PubMed ID: 9054576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level expression of mammalian protein farnesyltransferase in a baculovirus system. The purified protein contains zinc.
    Chen WJ; Moomaw JF; Overton L; Kost TA; Casey PJ
    J Biol Chem; 1993 May; 268(13):9675-80. PubMed ID: 8486655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-RAS peptide extensions as substrates for farnesyl-protein transferase and carboxymethyltransferase.
    Yoo Y; Watts S; Rechsteiner M
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):55-60. PubMed ID: 1322127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.